Missouri Chapter of the American College of Cardiology, 1693 S. Hanley Road, St. Louis, MO (2026)

02/13/2026

Almost time for pasta, stories, and real talk about career decisions in cardiology. 🍝💬

Power, Pay, & Practice: Making Informed Career Choices in Cardiology

🗓️ Wednesday, Feb. 19 | ⏰ 6:00 p.m.
📍 Pastaria, Clayton, MO

Fellows and early-career cardiologists—especially those connected with ACC Women in Cardiology, ACC Fellows in Training, SLU Fellows in Training, and Wash University Fellows in Training Fellowship Programs—are invited to join us for a relaxed evening focused on pay, practice models, and building a life that works.

👉 Seats are limited—don’t wait:
https://ow.ly/tP4K50Yann2

What’s more important to you right now: mentorship, flexibility, location, or compensation?

02/12/2026

If you’re scrolling over lunch and thinking about “what comes after fellowship,” this is for you. 🍝💬

MOACC is hosting:

Power, Pay, & Practice: Making Informed Career Choices in Cardiology

🗓️ Wednesday, Feb. 19
⏰ 6:00 p.m.
📍 Pastaria, 7734 Forsyth Blvd, Suite 1, Clayton, MO 63105

Fellows and early-career cardiologists are invited for an honest, off-the-record evening about:
▪️ Contracts, compensation, RVUs, and bonuses
▪️ Private vs academic vs hybrid practice—beyond the brochure
▪️ How to build a career that still leaves room for family, friends, and life outside the hospital

We’re looking forward to seeing colleagues from ACC Women in Cardiology, ACC Fellows in Training, SLU FIT, and Washington University FIT together in one room.

✅ Take 30 seconds while you eat to save your seat (limited):
https://ow.ly/XpYZ50Yanjp

Tag the co-fellow you’d want next to you for this conversation—who do you want in your corner when it’s time to sign?

02/10/2026

🆕 The ACC and AHA have released a new clinical guideline for the management of adults with congenital heart disease (ACHD).

This updated guidance:
▪️ Replaces the 2018 ACHD guideline
▪️ Provides current, evidence-based recommendations for monitoring, counseling, and treatment
▪️ Supports lifelong, specialized care for this growing patient population

📖 Explore the full guideline: https://bit.ly/3Y4KM0d

02/06/2026

Our patients’ stories deserve to be heard in the places where decisions are made. 🏛️❤️

On March 3, 2026, physicians, residents, fellows, medical students, and Alliance members from across Missouri will come together in Jefferson City for Physician Advocacy Day at the Millbottom Event Center.

This is a chance to:
▪️ Learn how to talk with legislators about real issues facing your patients and your practice
▪️ Meet colleagues from different specialties who care about the same things you do
▪️ Spend a focused day turning concern into action

Membership in MAOPS or MSMA is not required to participate.

✅ Register here:
https://ow.ly/Vej950Y4Z1c

Who in your clinic, hospital, or training program needs to see this and stand with you in Jefferson City?

02/06/2026

There’s a moment in training when the questions shift from “Will I pass boards?” to “What kind of life do I actually want in cardiology?” 🫀

MOACC is hosting an evening built for that moment:

Power, Pay, & Practice: Making Informed Career Choices in Cardiology

🗓️ Thursday, Feb. 19
⏰ 6:00 p.m.
📍 Pastaria, 7734 Forsyth Blvd, Suite 1, Clayton, MO 63105

Fellows and early-career cardiologists are invited for candid conversation about:
▪️ Contracts, compensation, and practice models
▪️ How to weigh location, call, and culture
▪️ Building a career that leaves room for real life

We’re excited to welcome colleagues from ACC Women in Cardiology, ACC Fellows in Training, SLU Fellows in Training, and Wash University Fellows in Training Fellowship Programs.

🔗 RSVP required (limited seating):
https://ow.ly/kvcN50Yanjn

When you picture your first (or next) job, what’s one non-negotiable you want to protect?

02/05/2026

🆕 The American College of Cardiology has released a Scientific Statement on managing cardiovascular peripheral artery disease (cvPAD) in adults with diabetes.

Designed to complement the 2024 ACC/AHA Lower Extremity PAD Guideline, this document:
▪️ Adds clinical context
▪️ Emphasizes a modern, evidence-based approach
▪️ Reinforces the importance of early screening through treatment

📖 Read the full statement: https://bit.ly/4oXzOEF

02/04/2026

High impact cath cases, four ACC chapters, one virtual room 💻🫀

The Virtual Cath Conference Series is back on Monday, February 9, 2026, jointly presented by the Illinois, Kansas, Missouri and Oklahoma ACC Chapters.

This fast paced, case based webinar will feature cath lab cases presented by representatives from the Illinois ACC, with discussion focused on:
▪️ Cardiogenic shock
▪️ High risk PCI
▪️ Structural interventions
▪️ Complication management
▪️ Cath lab diagnostic dilemmas

📍 Moderator: Quinn Capers IV, MD, FACC (Rush University School of Medicine, Chicago)

🎙️ Panelists:
▪️ Nikolaos Kakouros, MD, FACC, UMass Memorial Health, Worcester, MA
▪️ Mamata Alwarshetty, MD, FACC, Rush University School of Medicine, Chicago

🩺 Presenters:
▪️ Aneeq Wager, MD, SIU School of Medicine, Springfield
▪️ Mina Kerolos, MD, Endeavor Health NorthShore, Chicago
▪️ Ethan Loftspring, MD, Rush University School of Medicine, Chicago

Co organizers Steve Attanasio, DO, FACC and Abdul Moiz Hafiz, MD, FACC help bring this multi chapter effort together.

📅 Monday, February 9, 2026
⏰ 5:30 to 7:00 pm CT
🖥️ Webinar

Register here to join the conversation:
https://ilacc.starchapter.com/meet-reg1.php?id=35

Perfect for interventional cardiologists, cath lab teams, fellows in training, and anyone who loves real world, no fluff case discussion.

02/03/2026

🫀✨ While classic Hodgkin lymphoma is highly curable, the legacy of anthracyclines and thoracic radiation can include lasting cardiovascular damage.

This piece in JACC: CardioOncology reinforces the value of:

▪️ Early CV risk assessment
▪️ Cardio-protective strategies
▪️ Multidisciplinary survivorship care

The goal: save lives—and hearts.

📖 Read the article: https://www.jacc.org/doi/10.1016/j.jaccao.2025.07.011?utm_medium=social&utm_source=twitter_post&utm_campaign=twitter_post

01/30/2026

Membership dues are easy to see. What you get back is what really matters. 🫀

MOACC’s new article, “The ACC Advantage: Tools, Recognition & Community,” walks through how ACC membership can support you at every stage of your cardiology journey—from training to leadership. Highlights include:

▪️ Nationally recognized credentials like FACC/AACC and chances to serve on committees and sections
▪️ Clinical tools such as ClinicalKey AI and multiple ACC apps that bring guideline-based answers to the point of care
▪️ Access to JACC journals, big savings on ACC meetings, and lots of free CME/MOC
▪️ Member-only perks like malpractice premium savings and contract review services
▪️ Career support and networking through the ACC Career Center, DocMatter, and state chapters like MOACC

Full article here:
https://moacc.org/articles/accadvantage_0126

If you’re on the fence about joining or renewing, what benefit would make ACC feel like a true “must-have” for you in 2026—education, advocacy, networking, or practice tools?

01/29/2026

We’re used to thinking about PCSK9 inhibitors for patients who have already had a heart attack or stroke. But what about those who are clearly high risk and haven’t had that first event yet? 🫀

In a new Science Matters article, MOACC research fellow Michael Katsnelson, MD, PhD, FACC summarizes the VESALIUS-CV trial, which studied evolocumab in patients with atherosclerosis or high-risk diabetes but no prior MI or stroke.

Here are a few takeaways from his summary:
▪️ More than 12,000 patients were enrolled, almost all on background lipid therapy
▪️ Evolocumab cut LDL from around 115 to about 45 mg/dL
▪️ The drug reduced major adverse cardiovascular events (heart attack, coronary death, ischemic stroke, and ischemia-driven revascularization) compared with placebo
▪️ Longer follow-up (about 4.6 years) helped show the sustained benefit of aggressive LDL lowering

Dr. Katsnelson also raises an important idea: could future decisions about PCSK9 use be guided by overall plaque burden measured by imaging, not just LDL numbers alone?

Full article here:
https://moacc.org/articles/sciencematters_0126

When you think about your own patients with “no events yet” but significant atherosclerosis, what would make you most comfortable stepping up to a PCSK9 inhibitor?

01/28/2026

When people picture interventional cardiology, they often see the cath lab lights, STEMI call, and life-or-death decisions. What they don’t always see are the early alarms, school lunches, and hard choices about how to protect family time. 🫀👨‍👩‍👦

In a new MOACC feature, Dr. Jessica Birchem, Interventional Cardiologist at Mercy Springfield, opens up about her path—from being the first female interventional fellow in her program to leading a busy, high-acuity practice in Springfield nearly 15 years later.

She shares how she:
▪️ Chose interventional cardiology for its acuity and purpose
▪️ Evaluated job offers as a new mom with “time” as a non-negotiable
▪️ Balances cath lab days, STEMI activations, and leadership roles with being present for her kids
▪️ Uses early-morning workouts and big athletic goals (like a 70.3 triathlon) to protect her own well-being
▪️ Found a supportive group culture as the only woman in her interventional team

Full story here:
https://ow.ly/hkKJ50Y4ZyT

If you’re in cardiology training or early practice, what questions are you asking yourself about building a high-acuity career that still leaves room for the rest of your life?

01/27/2026

🎧 In this episode, explore key insights in cardiovascular care, including:

🫀 The PREVENT equations for assessing risk
🔬 Findings from the CREST-2 trials
🧑‍⚕️ Coaching as a strategy to reduce physician burnout
📦 Food labeling changes aimed at improving

🎙️ Listen here: https://bit.ly/48JW93V

Missouri Chapter of the American College of Cardiology

02/13/2026

02/12/2026

02/10/2026

02/06/2026

02/06/2026

02/05/2026

02/04/2026

02/03/2026

01/30/2026

01/29/2026

01/28/2026

01/27/2026

Address

Website

Alerts

Shortcuts

Share